Spinal Cord Injury Epidemiology Forecast

DelveInsight’s ‘Spinal Cord Injury- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical, and forecasted Spinal Cord Injury epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017–2030


Spinal Cord Injury: Understanding

The DelveInsight’s Spinal Cord Injury epidemiology report gives a thorough understanding of Spinal Cord Injury by including details such as disease classification, etiology, pathophysiology, biomarkers and diagnosis. It also provides treatment algorithms and treatment guidelines for Spinal Cord Injury in the US and Europe. Moreover, the report covers detailed information on the Spinal Cord Injury epidemiology scenario in seven major countries (US, EU5, and Japan).


Epidemiology Perspective by DelveInsight

This section encompassing Spinal Cord Injury epidemiology provides insights about historical and current patient pool and forecasted trends for every seven major countries. The Spinal Cord Injury epidemiology data are studied through all possible divisions to give a better understanding of the Disease scenario in 7MM. This segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports, and views of key opinion leaders.


Detailed Epidemiology Segmentation:

The Spinal Cord Injury epidemiology covered in the report provides historical as well as forecasted Spinal Cord Injury epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.


The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report:

  • The Spinal Cord Injury report covers a detailed overview explaining its etiology, pathophysiology classification, diagnosis and treatment patterns
  • The Spinal Cord Injury report and model provide an overview of the global trends of Spinal Cord Injury in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
  • The report provides insight into the historical and forecasted patient pool of Spinal Cord Injury in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
  • The report helps recognize the growth opportunities in the 7MM concerning the patient population.
  • The report assesses the disease risk and burden and highlights the unmet needs of Spinal Cord Injury.
  • The report provides the segmentation of the Spinal Cord Injury epidemiology


Report Highlights:

  • 11-year Forecast of Spinal Cord Injury Epidemiology
  • 7MM Coverage
  • Incidence of Spinal Cord Injury
  • Prevalence of Spinal Cord Injury( sub-segmented into gender, etiology, and neurological level)


KOL Views

We interview KOLs and include SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. It will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered:

  • What will be the growth opportunities in the 7MM concerning the patient population pertaining to Spinal Cord Injury?
  • What are the key findings pertaining to the Spinal Cord Injury epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2017–2030)?
  • What would be the total number of patients of Spinal Cord Injury across the 7MM during the forecast period (2017–2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017–2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017–2030)?
  • What are the disease risk, burden, and unmet needs of Spinal Cord Injury?
  • What are the currently available treatments of Spinal Cord Injury?


Reasons to buy:

The Spinal Cord Injury Epidemiology report will allow the user to:

  • Develop business strategies by understanding the trends shaping and driving the global Spinal Cord Injury market.
  • Quantify patient populations in the global Spinal Cord Injury market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Spinal Cord Injury therapeutics in each of the markets covered.
  • Understand the magnitude of Spinal Cord Injury population by its epidemiology.
  • The Spinal Cord Injury Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources.


Key Assessments:

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

 

1 Key Insights

2 Executive Summary of Spinal Cord Injury

3 SWOT Analysis for Spinal Cord Injury

4 Spinal Cord Injury Market Overview at a Glance

4.1 Market Share (%) Distribution of Spinal Cord Injury In 2017

4.2 Market Share (%) Distribution of Spinal Cord Injury In 2030

5 Disease Background and Overview

5.1 Introduction

5.2 Etiology and description of SCI

5.3 Classification of SCI and cord syndromes

5.4 Pathophysiology

5.4.1 SCI associated conditions

5.5 Complications

5.6 Assessment of SCI

5.7 Biomarkers

6 Epidemiology and Patient Population

6.1 Key Findings

6.2 Assumptions and Rationale: 7MM

7 Country Wise-Epidemiology of Spinal Cord Injury (SCI)

7.1 The United States

7.1.1 Incident cases of SCI

7.1.2 Prevalent cases of SCI

7.1.2.1 Gender-wise Prevalence of SCI

7.1.2.2 Prevalence of SCI by Causes

7.1.2.3 Prevalence of SCI at Neurological Level

7.2 EU-5 Countries

7.3 Germany

7.3.1 Incident cases of SCI

7.3.2 Prevalent cases of SCI

7.3.2.1 Gender-wise Prevalence of SCI

7.3.2.2 Prevalence of SCI by Causes

7.3.2.3 Prevalence of SCI at Neurological Level

7.4 France

7.4.1 Incident cases of SCI

7.4.2 Prevalent cases of SCI

7.4.2.1 Gender-wise Prevalence of SCI

7.4.2.2 Prevalence of SCI by Causes

7.4.2.3 Prevalence of SCI at Neurological Level

7.5 Italy

7.5.1 Incident cases of SCI

7.5.2 Prevalent cases of SCI

7.5.2.1 Gender-wise Prevalence of SCI

7.5.2.2 Prevalence of SCI by Causes

7.5.2.3 Prevalence of SCI at Neurological Level

7.6 Spain

7.6.1 Incident cases of SCI

7.6.2 Prevalent cases of SCI

7.6.2.1 Gender-wise Prevalence of SCI

7.6.2.2 Prevalence of SCI by Causes

7.6.2.3 Prevalence of SCI at Neurological Level

7.7 The UK

7.7.1 Incident cases of SCI

7.7.2 Prevalent cases of SCI

7.7.2.1 Gender-wise Prevalence of SCI

7.7.2.2 Prevalence of SCI by Causes

7.7.2.3 Prevalence of SCI at Neurological Level

7.8 Japan

7.8.1 Incident cases of SCI

7.8.2 Prevalent cases of SCI

7.8.2.1 Gender-wise Prevalence of SCI

7.8.2.2 Prevalence of SCI by Causes

7.8.2.3 Prevalence of SCI at Neurological Level

8 Treatment and Management

 Acute Spinal Cord Injury

 Chronic Spinal Cord Injury

8.1 Other interventions

8.1.1 Management of penetrating spine trauma

8.2 Post treatment complications and their management

8.3 Treatment Guidelines

 NICE Guidelines

 Consortium for Spinal Cord Medicine Guidelines

9 Case Study

 Penetrating Spinal Cord Injury

10 Patient Journey

11 Unmet Needs

12 Market Drivers

13 Market Barriers

14 Appendix

15.1 Report Methodology

16 DelveInsight Capabilities

17 Disclaimer

18 About DelveInsight

List of Table

Table 1: Summary of SCI Market, Epidemiology, and Key Events (2017–2030)

Table 2: The American Spinal Injury Association (ASIA) impairment scale

Table 3: Key-stages of the spinal cord response to closed trauma

Table 4: Incident Cases of SCI in the United States (2017–2030)

Table 5: Prevalent Cases of SCI in the United States (2017–2030)

Table 6: Gender-wise Prevalence of SCI in the United States (2017–2030)

Table 7: Prevalence of SCI by Causes in the United States (2017–2030)

Table 8: Prevalence of SCI at Neurological Level in the United States (2017–2030)

Table 9: Incident Cases of SCI in Germany (2017–2030)

Table 10: Prevalent Cases of SCI in Germany (2017–2030)

Table 11: Gender-wise Prevalence of SCI in Germany (2017–2030)

Table 12: Prevalence of SCI by Causes in Germany (2017–2030)

Table 13: Prevalence of SCI at Neurological Level in Germany (2017–2030)

Table 14: Incident Cases of SCI in France (2017–2030)

Table 15: Prevalent Cases of SCI in France (2017–2030)

Table 16: Gender-wise Prevalence of SCI in France (2017–2030)

Table 17: Prevalence of SCI by Causes in France (2017–2030)

Table 18: Prevalence of SCI at Neurological Level in France (2017–2030)

Table 19: Incident Cases of SCI in Italy (2017–2030)

Table 20: Prevalent Cases of SCI in Italy (2017–2030)

Table 21: Gender-wise Prevalence of SCI in Italy (2017–2030)

Table 22: Prevalence of SCI by Causes in Italy (2017–2030)

Table 23: Prevalence of SCI at Neurological Level in Italy (2017–2030)

Table 24: Incident Cases of SCI in the United States (2017–2030)

Table 25: Prevalent Cases of SCI in Spain (2017–2030)

Table 26: Gender-wise Prevalence of SCI in Spain (2017–2030)

Table 27: Prevalence of SCI by Causes in Spain (2017–2030)

Table 28: Prevalence of SCI at Neurological Level in Spain (2017–2030)

Table 29: Incident Cases of SCI in the United Kingdom (2017–2030)

Table 30: Prevalent Cases of SCI in the United Kingdom (2017–2030)

Table 31: Gender-wise Prevalence of SCI in the United Kingdom (2017–2030)

Table 32: Prevalence of SCI by Causes in the United Kingdom (2017–2030)

Table 33: Prevalence of SCI at Neurological Level in the United Kingdom (2017–2030)

Table 34: Incident Cases of SCI in Japan (2017–2030)

Table 35: Prevalent Cases of SCI in Japan (2017–2030)

Table 36: Gender-wise Prevalence of SCI in Japan (2017–2030)

Table 37: Prevalence of SCI by Causes in Japan (2017–2030)

Table 38: Prevalence of SCI at Neurological Level in Japan (2017–2030)

List of Figures

Figure 1: SWOT Analysis

Figure 2: Cascade of pathophysiological mechanisms

Figure 3: Overview of spinal cord injury pathophysiology

Figure 4:  Incident cases of SCI in the United States (2017–2030)

Figure 5: Prevalent Cases of SCI in the United States (2017–2030)

Figure 6: Gender-wise Prevalence of SCI in the United States (2017–2030)

Figure 7: Prevalence of SCI by Causes in the United States (2017–2030)

Figure 8: Prevalence of SCI at Neurological Level in the United States (2017–2030)

Figure 9:  Incident cases of SCI in Germany (2017–2030)

Figure 10: Prevalent Cases of SCI in Germany (2017–2030)

Figure 11: Gender-wise Prevalence of SCI in Germany (2017–2030)

Figure 12: Prevalence of SCI by Causes in Germany (2017–2030)

Figure 13: Prevalence of SCI at Neurological Level in Germany (2017–2030)

Figure 14: Incident cases of SCI in France (2017–2030)

Figure 15: Prevalent Cases of SCI in France (2017–2030)

Figure 16: Gender-wise Prevalence of SCI in France (2017–2030)

Figure 17: Prevalence of SCI by Causes in France (2017–2030)

Figure 18: Prevalence of SCI at Neurological Level in France (2017–2030)

Figure 19:  Incident cases of SCI in Italy (2017–2030)

Figure 20: Prevalent Cases of SCI in Italy (2017–2030)

Figure 21: Gender-wise Prevalence of SCI in Italy (2017–2030)

Figure 22: Prevalence of SCI by Causes in Italy (2017–2030)

Figure 23: Prevalence of SCI at Neurological Level in Italy(2017–2030)

Figure 24:  Incident cases of SCI in Spain (2017–2030)

Figure 25: Prevalent Cases of SCI in Spain(2017–2030)

Figure 26: Gender-wise Prevalence of SCI in Spain (2017–2030)

Figure 27: Prevalence of SCI by Causes in Spain (2017–2030)

Figure 28: Prevalence of SCI at Neurological Level in Spain (2017–2030)

Figure 29:  Incident cases of SCI in the United Kingdom (2017–2030)

Figure 30: Prevalent Cases of SCI in the United Kingdom (2017–2030)

Figure 31: Gender-wise Prevalence of SCI in the United Kingdom (2017–2030)

Figure 32: Prevalence of SCI by Causes in the United Kingdom (2017–2030)

Figure 33: Prevalence of SCI at Neurological Level in the United Kingdom (2017–2030)

Figure 34:  Incident cases of SCI in Japan (2017–2030)

Figure 35: Prevalent Cases of SCI in Japan (2017–2030)

Figure 36: Gender-wise Prevalence of SCI in Japan (2017–2030)

Figure 37: Prevalence of SCI by Causes in Japan (2017–2030)

Figure 38: Prevalence of SCI at Neurological Level in Japan (2017–2030)

Figure 39: Patient Journey for management of SCI

Figure 40: Unmet Needs

  • Tags:
  • Spinal Cord Injury Epidemiology
  • Spinal Cord Injury
  • Spinal Cord Injury Pipeline
  • Spinal Cord Injury Companies
  • Spinal Cord Injury prevalent popul...
  • Spinal Cord Injury incident popula...
  • Spinal Cord Injury patients diagno...
  • Spinal Cord Injury treatment algor...

Forward to Friend

Need A Quote